Clinical Trial

Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 23, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This pilot study is crucial to determining whether treating individuals who are at high risk for transmission or re-infection will impact HCV reinfection rates. It will establish the feasibility of DAA treatment in corrections facilities, as well as delineate the underlying immune basis of HCV cure and reinfection.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2015-05-29; most recent amendment 2024-08-21.
Status change: Not Yet Recruiting → Active, Not Recruiting 2016-02-01
Trial Details
NCT Number NCT02460133
Lead Sponsor Nova Scotia Health Authority
Collaborators: Provincial Correction Centre (PEI)
Conditions Hepatitis C Virus
Enrollment 44 participants
Start Date 2015-07-10
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-08-23